Adaptive Objective Configuration in Bi-Objective Evolutionary
Optimization for Cervical Cancer Brachytherapy Treatment Planning
- URL: http://arxiv.org/abs/2203.08851v1
- Date: Wed, 16 Mar 2022 18:16:33 GMT
- Title: Adaptive Objective Configuration in Bi-Objective Evolutionary
Optimization for Cervical Cancer Brachytherapy Treatment Planning
- Authors: Leah R.M. Dickhoff, Ellen M. Kerkhof, Heloisa H. Deuzeman, Carien L.
Creutzberg, Tanja Alderliesten, Peter A.N. Bosman
- Abstract summary: We propose a novel adaptive objective configuration method to use with MO-RV-GOMEA.
We show how, for 10 patient cases, the new approach achieves the intended result properly taking into account the additional aims.
- Score: 0.0
- License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
- Abstract: The Multi-Objective Real-Valued Gene-pool Optimal Mixing Evolutionary
Algorithm (MO-RV-GOMEA) has been proven effective and efficient in solving
real-world problems. A prime example is optimizing treatment plans for prostate
cancer brachytherapy, an internal form of radiation treatment, for which
equally important clinical aims from a base protocol are grouped into two
objectives and bi-objectively optimized. This use of MO-RV-GOMEA was recently
successfully introduced into clinical practice. Brachytherapy can also play an
important role in treating cervical cancer. However, using the same approach to
optimize treatment plans often does not immediately lead to clinically
desirable results. Concordantly, medical experts indicate that they use
additional aims beyond the cervix base protocol. Moreover, these aims have
different priorities and can be patient-specifically adjusted. For this reason,
we propose a novel adaptive objective configuration method to use with
MO-RV-GOMEA so that we can accommodate additional aims of this nature. Based on
results using only the base protocol, in consultation with medical experts, we
configured key additional aims. We show how, for 10 patient cases, the new
approach achieves the intended result, properly taking into account the
additional aims. Consequently, plans resulting from the new approach are
preferred by medical specialists in 8/10 cases.
Related papers
- Automated Treatment Planning for Interstitial HDR Brachytherapy for Locally Advanced Cervical Cancer using Deep Reinforcement Learning [3.9838929530763076]
The objective of this study is to develop a fully automated HDR brachytherapy planning framework.<n>We propose a hierarchical two-stage autoplanning framework.<n>For the unseen test patients, the RL-based automated planning method achieved an average score of 93.89%, outperforming the clinical plans which averaged 91.86%.
arXiv Detail & Related papers (2025-06-13T17:07:30Z) - Medical World Model: Generative Simulation of Tumor Evolution for Treatment Planning [50.16114813279694]
We introduce the Medical World Model (MeWM), the first world model in medicine that visually predicts future disease states based on clinical decisions.<n>MeWM comprises (i) vision-language models to serve as policy models, and (ii) tumor generative models as dynamics models.<n>We propose the inverse dynamics model that applies survival analysis to the simulated post-treatment tumor, enabling the evaluation of treatment efficacy and the selection of the optimal clinical action plan.
arXiv Detail & Related papers (2025-06-02T23:50:40Z) - Autonomous Radiotherapy Treatment Planning Using DOLA: A Privacy-Preserving, LLM-Based Optimization Agent [2.1986172572830096]
Dose Optimization Language Agent (DOLA) is an autonomous large language model (LLM)-based agent designed for optimizing radiotherapy treatment plans.
DOLA integrates the LLaMa3.1 LLM directly with a commercial treatment planning system.
operating entirely within secure local infrastructure.
arXiv Detail & Related papers (2025-03-21T22:01:19Z) - Towards Regulatory-Confirmed Adaptive Clinical Trials: Machine Learning Opportunities and Solutions [59.28853595868749]
We introduce two new objectives for future clinical trials that integrate regulatory constraints and treatment policy value for both the entire population and under-served populations.
We formulate Randomize First Augment Next (RFAN), a new framework for designing Phase III clinical trials.
Our framework consists of a standard randomized component followed by an adaptive one, jointly meant to efficiently and safely acquire and assign patients into treatment arms during the trial.
arXiv Detail & Related papers (2025-03-12T10:17:54Z) - DrugImproverGPT: A Large Language Model for Drug Optimization with Fine-Tuning via Structured Policy Optimization [53.27954325490941]
Finetuning a Large Language Model (LLM) is crucial for generating results towards specific objectives.
This research introduces a novel reinforcement learning algorithm to finetune a drug optimization LLM-based generative model.
arXiv Detail & Related papers (2025-02-11T04:00:21Z) - Pruning the Path to Optimal Care: Identifying Systematically Suboptimal Medical Decision-Making with Inverse Reinforcement Learning [14.688842697886484]
We present a novel application of Inverse Reinforcement Learning that identifies suboptimal clinician actions based on the actions of their peers.
This approach centers two stages of IRL with an intermediate step to prune trajectories displaying behavior that deviates significantly from the consensus.
arXiv Detail & Related papers (2024-11-07T23:16:59Z) - A Decision Making Approach for Chemotherapy Planning based on
Evolutionary Processing [0.0]
In this paper, a multi-objective meta-heuristic method is provided for cancer chemotherapy.
The proposed method uses mathematical models in order to measure the drug concentration, tumor growth and the amount of toxicity.
Results show that the proposed method achieve to a better therapeutic performance compared to a more recent similar method.
arXiv Detail & Related papers (2023-03-19T02:26:50Z) - Adaptive Identification of Populations with Treatment Benefit in
Clinical Trials: Machine Learning Challenges and Solutions [78.31410227443102]
We study the problem of adaptively identifying patient subpopulations that benefit from a given treatment during a confirmatory clinical trial.
We propose AdaGGI and AdaGCPI, two meta-algorithms for subpopulation construction.
arXiv Detail & Related papers (2022-08-11T14:27:49Z) - Strategising template-guided needle placement for MR-targeted prostate
biopsy [4.098030060686299]
We learn a reinforcement learning policy that optimises the actions of continuous positioning of 2D ultrasound views and biopsy needles.
Experiment results show that the proposed RL-learned policies obtained a mean hit rate of 93% and an average cancer core length of 11 mm.
arXiv Detail & Related papers (2022-07-21T23:27:07Z) - A Deep Bayesian Bandits Approach for Anticancer Therapy: Exploration via
Functional Prior [13.368491963797151]
personalized cancer treatment with machine learning holds great promise to improve cancer patients' chance of survival.
Despite recent advances in machine learning and precision oncology, this approach remains challenging.
We formulate drug screening study as a "contextual bandit" problem, in which an algorithm selects anticancer therapeutics based on contextual information about cancer cell lines.
We propose using a novel deep Bayesian bandits framework that uses functional prior to approximate posterior for drug response prediction based on multi-modal information consisting of genomic features and drug structure.
arXiv Detail & Related papers (2022-05-05T21:56:14Z) - Conditional Generation Net for Medication Recommendation [73.09366442098339]
Medication recommendation targets to provide a proper set of medicines according to patients' diagnoses, which is a critical task in clinics.
We propose Conditional Generation Net (COGNet) which introduces a novel copy-or-predict mechanism to generate the set of medicines.
We validate the proposed model on the public MIMIC data set, and the experimental results show that the proposed model can outperform state-of-the-art approaches.
arXiv Detail & Related papers (2022-02-14T10:16:41Z) - Real-time landmark detection for precise endoscopic submucosal
dissection via shape-aware relation network [51.44506007844284]
We propose a shape-aware relation network for accurate and real-time landmark detection in endoscopic submucosal dissection surgery.
We first devise an algorithm to automatically generate relation keypoint heatmaps, which intuitively represent the prior knowledge of spatial relations among landmarks.
We then develop two complementary regularization schemes to progressively incorporate the prior knowledge into the training process.
arXiv Detail & Related papers (2021-11-08T07:57:30Z) - The Medkit-Learn(ing) Environment: Medical Decision Modelling through
Simulation [81.72197368690031]
We present a new benchmarking suite designed specifically for medical sequential decision making.
The Medkit-Learn(ing) Environment is a publicly available Python package providing simple and easy access to high-fidelity synthetic medical data.
arXiv Detail & Related papers (2021-06-08T10:38:09Z) - Resource Planning for Hospitals Under Special Consideration of the
COVID-19 Pandemic: Optimization and Sensitivity Analysis [87.31348761201716]
Crises like the COVID-19 pandemic pose a serious challenge to health-care institutions.
BaBSim.Hospital is a tool for capacity planning based on discrete event simulation.
We aim to investigate and optimize these parameters to improve BaBSim.Hospital.
arXiv Detail & Related papers (2021-05-16T12:38:35Z) - Treatment Targeting by AUUC Maximization with Generalization Guarantees [7.837855832568568]
We consider the task of optimizing treatment assignment based on individual treatment effect prediction.
We propose a generalization bound on the Area Under the Uplift Curve (AUUC) and present a novel learning algorithm that optimize a derivable surrogate of this bound, called AUUC-max.
arXiv Detail & Related papers (2020-12-17T19:32:35Z) - MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
This paper aims at a unified deep learning approach to predict patient prognosis and therapy response.
We formalize the prognosis modeling as a multi-modal asynchronous time series classification task.
Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
arXiv Detail & Related papers (2020-10-08T15:30:17Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.